NCT03689569

Brief Summary

The study is primarily designed to examine the effect of 16 weeks of prebiotic supplementation (resistant starch)and moderate intensity aerobic training on markers of inflammation in stage 3-4 patients with chronic kidney disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 19, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 28, 2018

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 26, 2021

Completed
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

2.7 years

First QC Date

September 19, 2018

Last Update Submit

April 21, 2026

Conditions

Keywords

microbiomeinflammationresistant starchexercise training

Outcome Measures

Primary Outcomes (5)

  • Change in hs CRP

    hsCRP

    baseline and after 16 weeks

  • Change in TNF alpha

    TNFalpha

    Baseline and at week 16

  • Change in IL6

    IL6

    Baseline and at week 16

  • Change in IL10

    IL10

    Baseline and at week 16

  • Change in MCP1

    MCP1

    Baseline and at week 16

Secondary Outcomes (3)

  • Change in vascular function

    Baseline, week 8 and week 16

  • Change in microbiome composition

    Baseline and after 16 weeks

  • Change in blood pressure

    Baseline & after 16 weeks

Study Arms (4)

Exercise

EXPERIMENTAL

Exercise only: Patients randomized to this group will receive a placebo (corn starch) and be given 16 weeks of personal training.

Behavioral: Exercise

Resistant Starch

EXPERIMENTAL

Resistant starch only: Patients randomized to this group will receive 30 g of resistant starch daily for 16 weeks. They will not be given an exercise training

Dietary Supplement: Resistant starch

Exercise & Resistant Starch

EXPERIMENTAL

Exercise \& resistant starch: Patients assigned to this group will do 16 weeks of personal training and they will be supplemented with 30 g of resistant starch daily for the 16 week period

Dietary Supplement: Resistant starchBehavioral: Exercise

Starch

PLACEBO COMPARATOR

Corn starch only: Patients assigned to this group will not be given and exercise program and they will receive the placebo for 16 weeks

Behavioral: Starch

Interventions

Resistant starchDIETARY_SUPPLEMENT

Patients will receive 30 grams of resistant starch daily for 16 weeks or a placebo in a double blind fashion

Exercise & Resistant StarchResistant Starch
ExerciseBEHAVIORAL

Patients randomized to the exercise group will train aerobically for 16 weeks at a moderate exercise intensity

ExerciseExercise & Resistant Starch
StarchBEHAVIORAL

Patients will be given 30 grams of corn starch

Starch

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stage 3-4 of CKD (GFR 15-59 ml/min/1.73m2),
  • ages of 30-75 years old,
  • Must be capable of complying with and following the study protocol(diet and exercise)
  • Must be capable of independently giving informed consent

You may not qualify if:

  • kidney transplant
  • currently in a structured exercise program
  • on antibiotic therapy within the last month
  • On a probiotic or prebiotic supplement within the last month
  • a GI disorder that prohibits the use of resistant starch (ie. high-amylose corn starch, which resists digestion
  • HIV positive
  • gastric by-pass surgery
  • clostridium difficile
  • marijuana user
  • lupus
  • rheumatoid arthritis
  • Hepatitis C
  • Post-traumatic stress disorder
  • deep vein thrombosis
  • pancreatitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Springfield College

Springfield, Massachusetts, 01109, United States

Location

Related Publications (2)

  • Cooper TE, Khalid R, Chan S, Craig JC, Hawley CM, Howell M, Johnson DW, Jaure A, Teixeira-Pinto A, Wong G. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.

  • Headley SA, Chapman DJ, Germain MJ, Evans EE, Hutchinson J, Madsen KL, Ikizler TA, Miele EM, Kirton K, O'Neill E, Cornelius A, Martin B, Nindl B, Vaziri ND. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper. BMC Nephrol. 2020 Nov 26;21(1):517. doi: 10.1186/s12882-020-02177-x.

MeSH Terms

Conditions

Renal Insufficiency, ChronicInflammation

Interventions

Resistant StarchExerciseStarch

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

GlucansBiopolymersPolymersMacromolecular SubstancesDietary FiberDietary CarbohydratesCarbohydratesPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Samuel A Headley, PhD

    Springfield College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
This will be a double blind study. Neither the participant nor the investigator will know what substance (resistant starch or corn starch) the participants will be consuming.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: An Intention-To-Treat design will be used in this study. Effects of treatment on all dependent variables will be assessed by a 2 (prebiotic supplement or control) by 2 (aerobic exercise or control) by 3 (time) mixed factor ANOVA
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Exercise Science & Sport Studies

Study Record Dates

First Submitted

September 19, 2018

First Posted

September 28, 2018

Study Start

September 18, 2018

Primary Completion

May 26, 2021

Study Completion

May 26, 2021

Last Updated

April 24, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations